These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 20383192)
41. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells. Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629 [TBL] [Abstract][Full Text] [Related]
42. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982 [TBL] [Abstract][Full Text] [Related]
43. Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16. Yi JW; Jang M; Kim SJ; Kim SS; Rhee JE Oncol Rep; 2013 Apr; 29(4):1617-22. PubMed ID: 23404471 [TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625 [TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Zehbe I; Richard C; DeCarlo CA; Shai A; Lambert PF; Lichtig H; Tommasino M; Sherman L Virology; 2009 Jan; 383(1):69-77. PubMed ID: 18986660 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of TRAIL treatment against HPV16 infected cervical cancer cells undergoing senescence following siRNA knockdown of E6/E7 genes. Eaton S; Wiktor P; Thirstrup D; Lake D; Nagaraj VJ Biochem Biophys Res Commun; 2011 Feb; 405(1):1-6. PubMed ID: 21167816 [TBL] [Abstract][Full Text] [Related]
47. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506 [TBL] [Abstract][Full Text] [Related]
48. Oncogenic potential diverge among human papillomavirus type 16 natural variants. Sichero L; Sobrinho JS; Villa LL Virology; 2012 Oct; 432(1):127-32. PubMed ID: 22748253 [TBL] [Abstract][Full Text] [Related]
49. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. Liu X; Dakic A; Chen R; Disbrow GL; Zhang Y; Dai Y; Schlegel R J Virol; 2008 Dec; 82(23):11568-76. PubMed ID: 18818322 [TBL] [Abstract][Full Text] [Related]
50. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. Choi BS; Kim SS; Yun H; Jang DH; Lee JS J Med Virol; 2007 Apr; 79(4):426-30. PubMed ID: 17311337 [TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. Chakrabarti O; Veeraraghavalu K; Tergaonkar V; Liu Y; Androphy EJ; Stanley MA; Krishna S J Virol; 2004 Jun; 78(11):5934-45. PubMed ID: 15140991 [TBL] [Abstract][Full Text] [Related]
53. [Effects of human papillomavirus 16 E6 and E7 oncogene on the proliferation and differentiation of human laryngeal squamous cell carcinoma cell line]. Cai P; Wu ZY; Li JR Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Oct; 42(10):774-8. PubMed ID: 18229591 [TBL] [Abstract][Full Text] [Related]
55. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. Gabet AS; Accardi R; Bellopede A; Popp S; Boukamp P; Sylla BS; Londoño-Vallejo JA; Tommasino M FASEB J; 2008 Feb; 22(2):622-32. PubMed ID: 17898088 [TBL] [Abstract][Full Text] [Related]
56. Tumourigenesis driven by the human papillomavirus type 16 Asian-American e6 variant in a three-dimensional keratinocyte model. Jackson R; Togtema M; Lambert PF; Zehbe I PLoS One; 2014; 9(7):e101540. PubMed ID: 24983759 [TBL] [Abstract][Full Text] [Related]
57. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. McMurray HR; McCance DJ J Virol; 2004 Jun; 78(11):5698-706. PubMed ID: 15140967 [TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response. Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982 [TBL] [Abstract][Full Text] [Related]
59. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. Ordóñez RM; Espinosa AM; Sánchez-González DJ; Armendáriz-Borunda J; Berumen J J Gen Virol; 2004 Jun; 85(Pt 6):1433-1444. PubMed ID: 15166426 [TBL] [Abstract][Full Text] [Related]
60. [The study of gene variation and phylogenetic analysis of HPV16 E6 and E7 gene in Hubei, China]. Ding XH; Zhang F; Cai HB; Yang ZQ Bing Du Xue Bao; 2010 Sep; 26(5):368-72. PubMed ID: 21043136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]